Skip to main content
. 2014 May 16;8:965–972. doi: 10.2147/OPTH.S60292

Table 2.

Subject completion

Parameter Bromfenac 0.07%, n (%) Placebo, n (%)
Overall study completion 213/222 (95.9%) 202/218 (92.7%)
Full treatment (16 doses) received 143/222 (64.4%) 100/218 (45.8%)a
Percent compliance 91.2% 75.9%b
a

Notes: This was statistically significant (P=0.0001);

b

this was statistically significant (P<0.0001).